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OBJECTIVE: Studies suggest an association between vitamin D deficiency and morbidity/mortality in critically ill
patients. Several issues remain unexplained, including which vitamin D levels are related to morbidity and mortality
and the relevance of vitamin D kinetics to clinical outcomes. We conducted this study to address the association of
baseline vitamin D levels and vitamin D kinetics with morbidity and mortality in critically ill patients.
METHOD: In 135 intensive care unit (ICU) patients, vitamin D was prospectively measured on admission and
weekly until discharge from the ICU. The following outcomes of interest were analyzed: 28-day mortality,
mechanical ventilation, length of stay, infection rate, and culture positivity.
RESULTS: Mortality rates were higher among patients with vitamin D levelso12 ng/mL (versus vitamin D levels
412 ng/mL) (32.2% vs. 13.2%), with an adjusted relative risk of 2.2 (95% CI 1.07–4.54; po 0.05). There were no
differences in the length of stay, ventilation requirements, infection rate, or culture positivity.
CONCLUSIONS: This study suggests that low vitamin D levels on ICU admission are an independent risk factor for
mortality in critically ill patients. Low vitamin D levels at ICU admission may have a causal relationship with
mortality and may serve as an indicator for vitamin D replacement among critically ill patients.
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Vitamin D is a fat-soluble vitamin that is synthesized in the
skin in response to sunlight exposure (as provitamin D3 and
previtamin D3) and is also obtained, to a limited extent, from
dietary intake (vitamins D2 and D3). Vitamin D is stored in
adipose cells or is converted in the liver to its circulating
form, 25-hydroxyvitamin D3 [25(OH)D3]. Mainly in the
kidneys, 25(OH)D is converted to its active metabolite,
1,25-dihydroxyvitamin D [1,25(OH)2D], also known as
calcitriol. Calcitriol synthesis is enhanced by parathyroid
hormone (PTH) and hypophosphatemia. The endocrine
action of calcitriol on bone mineral metabolism has been
known for decades, and vitamin D supplementation has
been advocated in patients with chronic conditions, such as
osteoporosis. For many years, vitamin D deficiency was
recognized as a chronic condition associated with bone pain,
weakness and fractures in the general population. Serum
vitamin D levels below 10 ng/mL (generally described as
deficiency or severe deficiency) are associated with osteo-
malacia and rickets, whereas levels in the 20–30 ng/mL
range (vitamin D insufficiency or subclinical deficiency) are
associated with osteoporosis and elevated PTH and have the
potential to cause long-term harmful effects on bone
metabolism. Children with rickets are more susceptible to
infections, and vitamin D has been implicated in the
pathogenesis of tuberculosis (1–4). The paracrine and
autocrine effects of vitamin D have been increasingly
reported in the literature. In recent years, it has become
clear that several cell lines, including macrophages and
cardiac muscle cells, express vitamin D receptors and the
enzyme 25(OH)D3-1-alpha-hydroxylase, which allows the
cells to convert 25(OH)D to its active form, 1,25(OH)2D (5).
Studies have shown correlations between low vitamin D
levels and certain cancers, immune system dysfunction,
diabetes, cardiovascular disease, hypertension and metabolic
syndrome (6–8). Thus, investigators in several fields, includ-
ing critical care medicine, have turned their attention to the
nonskeletal effects of vitamin D (9-15). Some observational
studies have demonstrated a high prevalence of vitamin DDOI: 10.6061/clinics/2015(05)04
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deficiency in critically ill patients, who are generally
deprived of sunlight, confined to bed and fed diets with
low vitamin D content.
Data regarding the association between vitamin D
deficiency and poor ICU outcomes, such as mortality,
increased length of stay, increased length of mechanical
ventilation, and infections, are conflicting. After an initial
report by Lee et al. (16) suggesting a high prevalence of
vitamin D deficiency in critically ill patients, a retrospective
study involving 2,399 patients (14) showed an association
between vitamin D deficiency, mortality and positive blood
cultures. Subsequently, smaller prospective studies did not
find this association. Differences in the definition of vitamin
D deficiency, the studied populations (surgical ICUs versus
medical ICUs), the methodology of vitamin D measurement,
the interventions not measured (such as the volume and type
of solutions infused) and the geographical location may
account for the different findings in these studies (17,18-24).
The relevance of vitamin D measurement and kinetics at ICU
admission is open to debate. Furthermore, the 25(OH)D
levels required for proper maintenance of the pleiotropic
effects of vitamin D remain unknown.
The purpose of this study was to assess the relationship
between serum vitamin D levels at admission, vitamin D
kinetics during ICU stay, and morbidity and mortality in
critically ill patients.
’ MATERIALS AND METHODS
Study design and setting
This is a prospective study of patients admitted to the
medical-surgical ICU of a university hospital (Hospital de
Clínicas de Porto Alegre, state of Rio Grande do Sul, Brazil)
between March and November 2012. The city of Porto Alegre
is located in the South of Brazil at 30°05’S. The study protocol
was approved by the institutional research ethics committee,
and written informed consent was provided by all patients
or their surrogates.
Methods
We included adult patients (age 18 years and older) with a
predicted length of ICU stay greater than 3 days. We
excluded patients with a length of pre-ICU hospital stay
43 days, chronic renal failure requiring dialysis or pre
admission creatinine 42 mg/dL, a life expectancy of less
than 24 hours, pregnancy, admission for cardiac or elective
surgery, hyper- or hypoparathyroidism, and granulomatous
diseases, such as tuberculosis or sarcoidosis.
Patient demographic and clinical data were recorded on
ICU admission, including age, sex, comorbidities, current
medications, ethnicity, reason for admission, season,
APACHE II score, and body mass index (BMI) (Kg/m2).
The SOFA score was calculated at ICU admission and at ICU
discharge or death. Infections and cultures (blood, sputum,
urine, ascites or pleural fluid) were prospectively assessed
throughout the ICU stay for each patient. Patients were
considered infected when the attending physicians, who
were not involved with the study and had no access to serum
25(OH)D levels, diagnosed ICU-acquired infections and
prescribed antimicrobials to their patients. In addition to
the total number of positive cultures and clinically overt
infections, the incidence rates of culture positivity and
infection over time were also assessed. Patients were also
assessed for the duration of mechanical ventilation, length of
ICU stay, length of hospital stay, and 28-day mortality.
Biochemical analysis
Blood samples were collected within 24 hours of ICU
admission for the measurement of capillary blood glucose,
PTH, ionized calcium, albumin, creatinine, phosphorus,
magnesium, C-reactive protein, and lactate. The estimated
glomerular filtration rate was calculated using the MDRD
equation (10). All tests were performed by routine methods
employed at the biochemistry laboratory of Hospital de
Clínicas de Porto Alegre. 25(OH)D was measured once
weekly for 4 weeks or until ICU discharge. Samples were
protected from sunlight exposure, centrifuged and stored
under refrigeration until processing, which was performed
once weekly on Fridays. 25(OH)D levels were measured
using the chemiluminescence method (Liaison; Diasorin,
Stillmater, Minnesota; inter- and intra-assay coefficients of
variation, 10%) and reported in ng/mL (11). (To convert the
25(OH)D concentration from ng/mL to nmol/L, multiply by
2.5.) PTH levels were measured by a chemiluminescent
immunoassay (Advia Centaur XP; Siemens Healthcare
Diagnostics Inc.).
Statistical analysis
Normally distributed quantitative variables are expressed
as the mean ± standard deviation. Asymmetrically dis-
tributed variables are expressed as the median [interquartile
range]. The chi-square test was used for the assessment of
categorical variables, and Student’s t-test was used for
continuous variables. Normally distributed and asymmetric
variables were compared using the Mann–Whitney U test.
Receiver-operating characteristic (ROC) curves were plotted
to illustrate 25(OH)D cutoff values. Relative risks (along with
95% confidence intervals) were estimated using Poisson
regression adjusted for 6 covariates: lactate, albumin, SOFA
and APACHE II scores, sepsis as the reason for ICU
admission and BMI. Survival analysis was performed by
means of Kaplan-Meier curves. Log-rank statistics were used
to determine significant differences over time. For the
comparative analysis of changes in the 25(OH)D levels over
time during ICU admission between survivors and non-
survivors, we used a generalized estimating equation model
for longitudinal data analysis (12). Infection and culture
positivity rates were compared by means of incidence




Overall, 135 patients were included. The 28-day mortality
rate was 21.5%. Slightly less than half of all patients (47%)
were women, and 78% were Caucasian. The median vitamin
D level at admission was 13.3 [8.1–20] ng/mL. Only 16
patients (11.8%) were vitamin D sufficient (25(OH)
D430 ng/mL); 101 (74.8%) were vitamin D insufficient
(25(OH)Do20 ng/mL). Five patients were on bisphospho-
nate, calcium, and vitamin D therapy prior to admission.
These patients’ 25(OH)D levels ranged from 4.7 ng/mL to
18 ng/mL. No patient received supplemental vitamin D
during his or her ICU stays. The sample profile is shown in
Table 1. Non-survivors had higher APACHE II and SOFA
scores and PTH and lactate levels on admission and had
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more difficult clinical courses with more organ dysfunction
(lower DSOFA). In addition, fewer progressed to enteral
feeding; five patients were never fed due to death secondary
to refractory shock within the first few days of ICU
admission. Electrolytes and renal function were assessed in
117 patients who were not on dialysis at the time of 25(OH)D
measurement. Non-survivors had lower ionized calcium
levels and lower glomerular filtration rates (Table 2).
Table 1 - Sample profile.
Survivors (n=106) Non-survivors (n=29) p-value
Age, years 55.4±16.1 60.4±16.6 0.141
Gender, n (%)
Female 48 (45%) 16 (55%) 0.462
Male 58 (55%) 13 (45%)
Comorbidities, n (%)
Coronary artery disease 12 (11.3%) 3 (10%) 0.882
Hypertension 54 (51%) 14 (48%) 0.964
Heart failure 13 (12%) 3 (10%) 1.000
Diabetes 27 (25%) 6 (21%) 0.774
Hypothyroidism 3 (2.8%) 3 (10%) 0.113
Chronic renal failure 3 (2.8%) 1 (3.4%) 1.000
COPD 19 (18%) 5 (17%) 1.000
Asthma 4 (3.8%) 3 (10%) 0.169
AIDS 8 (7.5%) 0 0.201
Cirrhosis 9 (8.5%) 3 (10%) 0.720
Stroke 7 (6.6%) 4 (14%) 0.249
Depression 8 (7.5%) 0 0.201
Neoplasia 14 (13%) 5 (17.2%) 0.557
Other 20 (19%) 7 (24%) 0.714
Chronic medications, n (%)
Diuretic 28 (26.4%) 11 (38%) 0.326
Corticosteroid 8 (7.5%) 5 (17%) 0.125
Ca/VITD 3 (2.8%) 2 (7%) 0.292
Bisphosphonate 1 (1%) 1 (3.4%) 0.385
Antiepileptic 4 (3.8%) 3 (10.3%) 0.169
Proton pump inhibitor 10 (9.4%) 1 (3.4%) 0.456
Ethnicity, n (%) 0.660
Caucasian 83 (78.3%) 22 (75.9%)
African 14 (13.2%) 3 (10.3%)
Other 9 (8.5%) 4 (13.8%)
Reason for ICU admission, n (%) 0.009
Sepsis 34 (32%) 14 (48%)
Acute respiratory failure 17 (16%) 3 (10%)
Post-surgery 5 (4.7%) 1 (3.4%)
Post-cardiac arrest 4 (3.8%) 1 (3.4%)
Coma 4 (3.8%) 5 (17%)*
Non-septic shock 4 (3.8%) 3 (10%)
Acute renal failure 4 (3.8%) 0
Other 34 (32%)* 2 (7%)
Provenance, n (%) 0.839
Emergency department 73 (69%) 21 (72%)
Ward 2 (1.9%) 0
Operating theater 11 (10%) 2 (7%)
Other 20 (30%) 6 (20.7%)
Admission service, n (%) 0.924
Medical 80 (75%) 21 (72%)
Surgical 26 (25%) 8 (28%)
Season of admission, n (%) 0.577
Summer 23 (22%) 4 (14%)
Autumn 36 (34%) 8 (27.5%)
Winter 28 (26%) 10 (34.5%)
Spring 19 (18%) 7 (24%)
APACHE II score 17 [12 to 23] 23 [18 to 29] 0.001
SOFA score 4.5 [2 to 8] 7 [4.5 to 12] 0.001
DSOFA 3.0 [1 to 6] 2 [5.5 to 1.5] 0.001
BMI (Kg/m2) 26.7 [23.3 to 30.5] 26.5 [23.5 to 31.6] 0.823
Capillary blood glucose (mg/dL) 146 [113 to 193] 141 [99 to 189] 0.485
Albumin (g/dL) 3.1±0.6 2.7±0.8 0.004
CRP (mg/L) 83 [28 to 231] 168 [23 to 264] 0.316
Lactate (mmol/L) 1.4 [1 to 2.1] 3.1 [1.4 to 5.6] 0.001
PTH (pg/mL) 97.9 [56.8 to 198.6] 200.8 [92.6 to 331] 0.023
COPD, chronic obstructive pulmonary disease; Ca/VITD: calcium/vitamin D ratio; DSOFA, SOFA on admission - final SOFA (at ICU discharge or death); BMI,
body mass index (Kg/m2); CRP, C-reactive protein; PTH, parathyroid hormone. * denotes a statistically significant change. Summer: December 21 to March
21. Autumn: March 21 to June 21. Winter: June 21 to September 23. Spring: September 23 to December 21.
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The area under the ROC curve for 25(OH)D levels at
admission in relation to mortality was 0.61 (95%CI 0.49–
0.73), similar to those for APACHE II (0.7, 95% CI 0.59–0.8)
and SOFA scores (0.7, 95% CI 0.6–0.8). The best cutoff was
11.9 ng/mL, with a sensitivity of 65%, a specificity of 62%, a
negative predictive value of 86.8%, and a positive predictive
value of 32.2% (Figure 1).
Compared with patients with 25(OH)D levels 412 ng/mL,
the 59 patients with 25(OH)Dp12 ng/mL (43.7% of the sample)
had higher prevalence rates of prior corticosteroid therapy (18%
vs. 2.6%; p=0.005) and of acute respiratory failure as a reason for
ICU admission (25% vs. 6.6%; p=0.013). Although there is no
difference between the median vitamin D levels among seasons,
a seasonal association was found for the prevalence of
vitamin D deficiency (p=0.041), which was more common in
the winter (37.3% vs. 21%) and less common in the summer
(10.2% vs. 27.6%). Vitamin D-deficient patients had higher BMIs
(27.4 Kg/m2 [24.2–35.2] vs. 26 Kg/m2 [22.7–29.3]; p=0.015).
There were no differences in APACHE II scores (19.8±9 vs.
18.7±8.3; p=0.482), SOFA scores at admission (5 [2–8] vs. 5 [3–8];
p=0.170), albumin (3.08±0.78 g/dL vs. 3.06±0.6 g/dL; p=0.87),
ionized calcium (4.7 [4.4–5.0] mg/dL vs. 4.7 [4.5–4.8] mg/dL;
p=0.770), or PTH (146 [79–260] pg/mL vs. 107 [53–200]; p=0.70),
which was elevated in both groups. Patients with 25(OH)D
levelsp12 ng/mL developed greater organ system dysfunction
during their ICU stays (DSOFA: 0.9±4.7 vs. 3.4±3.9; p=0.001).
Mortality
Over the course of the 28-day observation period, 19 of the
59 patients with 25(OH)D levels p12 ng/mL died (32.2%),
compared with 10 of the 76 patients with 25(OH)D
levels 412 ng/mL (13.2%); this difference was statistically
significant (p=0.014). The crude relative risk of death was
2.11 (95% CI 1.08–4.11). After multivariable adjustment,
the relative risk remained significantly higher, at 2.20 (95% CI
1.07–4.54) (Table 3).
There were no significant differences in mortality (23.5%
vs. 15.2%; p=0.275) when the 25(OH)D cutoff was set at
20 ng/mL.
Length of stay
25(OH)D levelsp12 ng/mL were not associated with any
significant differences in the overall length of hospital stay
(20 [9–28] vs. 23.5 [14–28], p=0.869) or length of ICU stay
(9 [5–21] vs. 9 [5–21], p=0.092), in days.
Mechanical ventilation
Invasive mechanical ventilation was used in 44 (74.6%)
patients with 25(OH)D levels p12 ng/mL and in 59 (77.7%)
patients with 25(OH)D levels 412 ng/mL (p=0.834).
Infection and culture positivity
Overall, 78 patients (57.8%) had positive cultures at some
point during their ICU stays. Among the 59 patients with
25(OH)Dp12 ng/mL, a total of 73 infections and 101
positive cultures (including 28 positive blood cultures) were
detected. Among the 76 patients with 25(OH)D412 ng/mL,
88 infections and 121 positive cultures (including 32 positive
blood cultures) were detected. The rates of infection and
culture positivity per 100 patient-days in the ICU are shown
in Table 4. There were no significant differences between
groups for either indicator.
Vitamin D kinetics
A slight decrease in 25(OH)D concentrations occurred over
time, reaching statistical significance only on day 21 among
all patients. Among non-survivors, a non-significant decline
in 25(OH)D levels occurred at the 14th day of ICU stay. The
decline in vitamin 25(OH)D levels through ICU stay were
not related to mortality or other clinical outcomes.
’ DISCUSSION
Our findings show that severe vitamin D deficiency is an
independent predictor of mortality in critically ill patients. In
this sample, a 25(OH)D level of 12 ng/mL was the best
cutoff for the identification of critically ill patients at a higher
risk of death.
The relationship between mortality and serum vitamin D
levels in critically ill patients is a topic of debate in the
current literature (13). While some studies have reported
such an association (14–21), others have not (22–27). The
higher mortality rate among severely vitamin D-deficient
Table 2 - Electrolyte levels and renal function of patients not on acute dialysis at the time of laboratory testing.
Survivors (n=95) Non-survivors (n=22) p-value
Ca++ (mg/dL) 4.7 [4.6–4.9] 4.4 [3.8–4.7] 0.001
GFR (mL/min/1.73 m2) 60 [48–60] 59 [26–60] 0.042
Phosphorus (mg/dL) 2.9 [2.3–4.2] 3.2 [2.7–4.3] 0.334
Magnesium (mg/dL) 2.0±0.4 1.9±0.36 0.345
GFR: glomerular filtration rate calculated by the Modification of Diet in Renal Disease Study Group (MDRD). Values are expressed as the total mean ±
95% confidence interval OR the median [interquartile range].
Figure 1 - Receiver-operating characteristic curve for various
cutoff levels of vitamin D [25(OH)D].
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subjects found in this study is in agreement with the
retrospective studies of Braun et al (14–15). Our study
confirms these findings with a prospective design and also
demonstrates that the increased mortality attributed to
vitamin D deficiency persists even after adjusting the risk
for variables associated with mortality. Notably, APACHE II
and SOFA scores on admission were similar in 25(OH)D-
deficient and non-deficient patients. Nevertheless, the
mortality rate was higher in the 25(OH)D-deficient group.
In 2012, Higgins et al. (24) conducted a prospective study
and found no significant differences in mortality among
critically ill vitamin D-deficient patients, although deficient
patients had longer ICU lengths of stay. The authors note
that their study was not powered to detect differences in
mortality. Heterogeneity between studies may explain the
different results. The Higgins et al sample was older, and
data collection occurred between 2002 and 2003 in Canada,
while our data collection occurred in 2012 in Southern Brazil.
In our study, we excluded patients with a total length of
hospital stay 43 days before ICU transfer, whereas Higgins
et al had no such exclusion criterion. We thus excluded
patients with normal pre-admission vitamin D levels whose
decrease in serum 25(OH)D levels was attributable to
hospitalization. Our sample had a higher prevalence of
sepsis as the reason for ICU admission. Some studies have
suggested that this etiology may be associated with higher
mortality related to vitamin D deficiency (6).
Vitamin D may be no more than a marker of severity in
critically ill patients. However, the literature reports several
vitamin D-dependent physiological mechanisms, suggesting
that 25(OH)D deficiency may be implicated in the pathogen-
esis of organ dysfunction and mortality in critically ill
patients, perhaps mediated by its effects on immunity and on
the cardiovascular system (6,7,27-29). As ours was an
observational study, we cannot ascertain whether the
association between vitamin D deficiency and mortality is
causal or attributable to chance. However, even after logistic
regression, 25(OH)D levels o12 ng/mL remained an inde-
pendent predictor of mortality.
The current literature provides no information on the
25(OH)D level that can adequately support the pleiotropic
effects of vitamin D. In our population, ROC curve analysis
identified 12 ng/mL as the best cutoff for mortality. This
finding is similar to that reported in a retrospective study
(18). Even if 25(OH)D is merely a marker of severity, these
studies suggest that vitamin D levels o10–12 ng/mL can be
used to identify patients at a higher risk of mortality and can
prompt more intensive monitoring of these patients. In non-
critically ill patients, 25(OH)D levels this low are incapable of
maintaining serum concentrations of 1,25(OH)2D, leading to
clinical repercussions such as rickets and osteomalacia. This
study suggests that, similarly to outpatients, critically ill
patients with severe vitamin D deficiency suffer the most
clinical consequences from the lack of vitamin D; from this
finding, we infer that these patients are most likely to benefit
from vitamin D replacement during the ICU stay. This
hypothesis must still be confirmed by clinical trials. Dietary
vitamin D intake is reduced in critically ill patients. Enteral
formulas provide 200 to 300 IU/1000 mL, as do multi-
vitamins. The current recommended daily intake of 200 IU/
day is not enough to restore vitamin D to a sufficient level
(30). Two recent studies showed that higher (yet safe) doses
are required for vitamin D replacement in critically ill
patients (31,32). Our results also align with those of a
recently published clinical trial (33). In this trial, patients
randomized to the intervention group received a loading
dose of 540,000 IU of vitamin D followed by 90,000 IU
monthly for 5 months. The analysis of the subgroup of
patients with baseline levels of vitamin D o10 ng/mL
showed a decrease in mortality. This result requires
confirmation in future multicenter randomized clinical trials
before a therapeutic recommendation can be generated.
As in other prospective studies (24,34), we found no
significant differences in infection and culture positivity rates
between vitamin D-deficient and non-deficient patients.
Previous studies have shown a trend toward a greater
incidence of infections but have lacked the statistical power
to conclusively establish this association. Higher rates of
Table 3 - Crude and adjusted mortality by Poisson regression.
Crude relative risk 95% CI Adjusted relative risk 95% CI
Vitamin D (25[OH]D3 p 12 ng/mL) 2.11 1.08–4.11 2.20 1.07–4.54
APACHE II 1.06 1.03–1.09 1.03 0.99–1.8
SOFA 1.11 1.06–1.17 1.04 0.97–1.11
Lactate 1.17 1.07–1.17 1.04 0.99–1.10
Albumin 0.58 0.38–0,88 0.75 0.47–1,19
BMI 1.01 0.96–1.05 0.99 0.95–1.03
Sepsis 1.00 0.63–1.58 1.06 0.54–2.07
APACHE II: Acute Physiology and Chronic Health Disease Classification System II; SOFA: Sequential Organ Failure Assessment; BMI: body mass index
(Kg/m2); CI: confidence interval.
Table 4 - Mortality, mechanical ventilation and culture positivity according to vitamin D (25[OH]D3) status.
25[OH]D3 p 12 ng/mL 25[OH]D3 4 12 ng/mL p-value
28-day mortality, % 32.2 13.2 0.014
Mechanical ventilation,% 74.6 77.4 0.834
Infections* 10.08 8.98 0.468
Positive cultures* 13.95 12.35 0.369
Positive blood cultures* 3.86 3.26 0.516
ICU: Intensive Care Unit
*Rate of infections per 100 patient-days in ICU
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infection and culture positivity have been observed among
vitamin D-deficient patients in retrospective studies (14),
which, despite design bias, are able to include larger
samples.
Although the literature suggests an association between
25(OH)D deficiency and morbidity in critically ill patients,
our study did not find a longer duration of mechanical
ventilation among patients with severe vitamin D deficiency.
These results are consistent with other recently published
prospective studies conducted in critically ill adult (17,18,21)
and pediatric (26) populations.
In this study, we observed a modest decrease in 25(OH)D
levels in critically ill patients, with a tendency toward lower
levels among non-survivors. Only two other studies have
prospectively measured vitamin D levels during the course
of an ICU stay (24,28). In both studies, data collection was
restricted to 7 and 10 days of hospitalization. In our study,
we measured 25(OH)D levels once weekly until the 28th day
in the ICU and found that non-survivors may have
experienced a greater decrease in 25(OH)D concentrations
after the second week in the ICU. As the half-life of 25(OH)D
is approximately 15 days, these findings partly reflect the
lack of vitamin D intake during the ICU stay due to a lack of
sunlight exposure and low vitamin D concentrations in the
diet provided to critically ill patients. Prior studies have
shown a decrease in vitamin D-binding protein (VDBP)
concentrations during an ICU stay (29), corroborating the
decline in 25(OH)D levels during admission, particularly in
non-survivors. This behavior is analogous to that observed
with other constitutional proteins, the synthesis of which is
inhibited as metabolic pathways shift to the production of
acute phase proteins in the setting of systemic inflammatory
response syndrome (SIRS). Therefore, the criticality of the
illness may also be reflected by serum vitamin D levels.
The high prevalence of vitamin D deficiency and insuffi-
ciency observed in our sample is consistent with other
studies carried out at other centers, as well as with the high
prevalence found in the non-critically ill population in our
center (35). We are unaware of other reports of the
prevalence and incidence of vitamin D deficiency in critically
ill patients in South and Central America.
This study has some limitations. It was conducted at a
tertiary care center with a largely Caucasian population and
a relatively small sample size. The infection rate was solely
calculated based on clinical diagnoses made by the assisting
physicians. We cannot completely rule out the potential
influence of unassessed variables—such as the volume
infused in the first hours after admission or the cause of
death—on mortality (36). Vitamin D measurements were not
performed in duplicate. VDBP and biologically active
25(OH)D metabolites were not measured. Notably, albumin
levels did not differ according to the vitamin D status.
Importantly, the pleiotropic effects of vitamin D are
dependent on local vitamin D concentrations; it is biologi-
cally plausible that these effects would be independent of
serum 25(OH)D levels. Furthermore, the association between
mortality and severe vitamin D deficiency found in this
observational study is not enough to recommend the
measurement of vitamin D levels in critically ill patients or
supplementation in those with vitamin D deficiency; such
changes in practice would depend on the results of clinical
trials, which are ongoing.
The strengths of this study include its assessment of a hard
endpoint (mortality) that is not prone to measurement bias.
In addition to 25(OH)D levels, we measured other compo-
nents that affect the vitamin D axis such as PTH, ionized
calcium, magnesium, and phosphorus. The method
employed for 25(OH)D measurement was the DiaSorin
radioimmunoassay, which is currently considered the stan-
dard for this purpose in view of its excellent agreement with
isotope dilution liquid chromatography-tandem mass spec-
troscopy (LC-MS) (13,37).
In our study, PTH levels were higher among non-
survivors. The elevation of PTH among critically ill patients
is due to factors such as peripheral resistance to the action of
PTH, especially in the acute phase, in hypovitaminosis D and
in hypocalcemia, and may be related to morbidity in
critically ill patients (38). Thus, PTH itself appears to be a
marker of severity, as observed with TSH or cortisol;
however, PTH does not appear to be a potential therapeutic
target, unlike vitamin D.
This study found that low vitamin D levels on admission
are an independent risk factor for mortality in critically ill
patients. The best cutoff of 25(OH)D levels on admission for
stratifying the risk of death among critically ill patients was
12 ng/mL. As well as being markers of disease severity, low
vitamin D levels and vitamin D kinetics during ICU
admission may be causally associated with mortality and
may serve as indicators for vitamin D supplementation in
this patient population. Nevertheless, randomized trials are
required to confirm this hypothesis.
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